Short Interest in Revolution Medicines, Inc. Declines By 91.5
| RVMDW Stock | 0.36 0.04 11.18% |
Slightly above 59% of Revolution Medicines,'s investor base is looking to short. The analysis of the overall investor sentiment regarding Revolution Medicines, Warrant suggests that many traders are alarmed. Revolution Medicines,'s investing sentiment can be driven by a variety of factors including economic data, Revolution Medicines,'s earnings reports, geopolitical events, and overall market trends.
Revolution |
Revolution Medicines, Inc. was the target of a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 400 shares, a drop of 91.5 percent from the October 31st total of 4,700 shares. Based on an average trading volume of 35,900 shares,
Read at thelincolnianonline.com
 |
Revolution Medicines, Fundamental Analysis
We analyze Revolution Medicines,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revolution Medicines, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revolution Medicines, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Revolution Medicines, is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Revolution Medicines, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Revolution Medicines, stock to make a market-neutral strategy. Peer analysis of Revolution Medicines, could also be used in its relative valuation, which is a method of valuing Revolution Medicines, by comparing valuation metrics with similar companies.
Peers
Revolution Medicines, Related Equities
| MTEX | Mannatech Incorporated | 7.46 | ||||
| RIG | Transocean | 2.33 | ||||
| VRA | Vera Bradley | 1.39 | ||||
| PDS | Precision Drilling | 1.17 | ||||
| TKR | Timken | 0.85 | ||||
| UL | Unilever PLC | 0.17 | ||||
| PG | Procter Gamble | 0.06 |
Additional Tools for Revolution Stock Analysis
When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.